Correlation Between IShares Nasdaq and IShares VII

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Nasdaq and IShares VII at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Nasdaq and IShares VII into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Nasdaq Biotechnology and iShares VII Public, you can compare the effects of market volatilities on IShares Nasdaq and IShares VII and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Nasdaq with a short position of IShares VII. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Nasdaq and IShares VII.

Diversification Opportunities for IShares Nasdaq and IShares VII

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between IShares and IShares is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding iShares Nasdaq Biotechnology and iShares VII Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares VII Public and IShares Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Nasdaq Biotechnology are associated (or correlated) with IShares VII. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares VII Public has no effect on the direction of IShares Nasdaq i.e., IShares Nasdaq and IShares VII go up and down completely randomly.

Pair Corralation between IShares Nasdaq and IShares VII

Assuming the 90 days trading horizon iShares Nasdaq Biotechnology is expected to under-perform the IShares VII. In addition to that, IShares Nasdaq is 1.96 times more volatile than iShares VII Public. It trades about -0.11 of its total potential returns per unit of risk. iShares VII Public is currently generating about -0.12 per unit of volatility. If you would invest  1,462,900  in iShares VII Public on August 26, 2024 and sell it today you would lose (32,200) from holding iShares VII Public or give up 2.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

iShares Nasdaq Biotechnology  vs.  iShares VII Public

 Performance 
       Timeline  
iShares Nasdaq Biote 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, IShares Nasdaq is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
iShares VII Public 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in iShares VII Public are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, IShares VII is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

IShares Nasdaq and IShares VII Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Nasdaq and IShares VII

The main advantage of trading using opposite IShares Nasdaq and IShares VII positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Nasdaq position performs unexpectedly, IShares VII can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares VII will offset losses from the drop in IShares VII's long position.
The idea behind iShares Nasdaq Biotechnology and iShares VII Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
CEOs Directory
Screen CEOs from public companies around the world